Abstract
Introduction
Platycodi radix is a radish used in food, such as Korean kimchi, and has been shown to cause weight loss in rodents. Platycodin D is considered its active ingredient and has been shown to inhibit lipases. The authors hypothesized that platycodi radix and the platycodin D it contains inhibit angiogenesis; another mechanism for weight loss.
Methods
This study tested platycodi radix extract, platycodin D, and an extract of platycodi radix standardized to platycodin D for their ability to inhibit angiogenesis in a human adipose tissue assay. This study treated five healthy volunteers, orally, with platycodi radix extract standardized to 414 mg of platycodin D. Three volunteers were treated under fasting conditions, one volunteer with a 400 kcal meal, and one volunteer treated with a placebo. Blood was drawn over 5 hours to compare serum inhibition of the human adipose tissue angiogenesis.
Results
Platycodin radix extract, platycodin D, and platycodi radix extract standardized to platycodin D all inhibited angiogenesis. The three volunteers who consumed platycodi radix extract standardized to 414 mg of platycodin D had a 25.76% reduction in angiogenesis from baseline at 60 minutes (P<0.002), and had a statistically significant reduction in angiogenesis from 30 to 240 minutes (P<0.05 to P<0.002). The placebo decreased angiogenesis by 5.6% between 30 and 240 minutes, compared with 17.8% by the extract. The meal delayed absorption by approximately 3.5 hours.
Conclusion
Platycodi radix extract standardized to platycodin D inhibited angiogenesis in human volunteers, and paves the way for a dose-response study and a human clinical obesity trial.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore. 2009;38:57–59.
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–241.
Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727.
Bray GA. Obesity: a time bomb to be defused. Lancet. 1998;352:160–161.
Skyler JS, Oddo C. Diabetes trends in the USA. Diabetes Metab Res Rev. 2002;18(suppl. 3):S21–26.
Ferdinand KC, Clark LT. The epidemic of diabetes mellitus and the metabolic syndrome in African Americans. Rev Cardiovasc Med. 2004;5(suppl. 3):S28–33.
Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6:97–106.
Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917–932.
National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998;6(suppl. 2):51S–209S [Published erratum appears in Obes Res. 1998:6:464].
Wadden TA, Butryn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obes Res. 2004;12(suppl.): 151S–62S.
Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev. 1999;20:805–875.
Greenway FL. Surgery for obesity. Endocrinol Metab Clin North Am. 1996;25:1005–1027.
Pharmacopoeia of the People’s Republic of China (English ed.). Guangzhou, Guangdong Science and Technology Press, 1992.
Method for producing platycodi radix root kimchi. Available at http://www.sumobrain.com/patents/jp/Method-producing-platycodi-radix-root/JP2002186416.html. Accessed December 5, 2010.
Han LK, Xu BJ, Kimura Y, Zheng Y, Okuda H. Platycodin radix affects lipid metabolism in mice with high fat diet-induced obesity. J Nutr. 2000;130:2760–2764.
Han LK, Zheng YN, Xu BJ, Okuda H, Kimura Y. Saponins from platycodin radix ameliorate high fat diet-induced obesity in mice. J Nutr. 2002;132:2241–2245.
Zhao HL, Sims JS, Shim SH, Ha YW, Kang SS, Kim Ys. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidence for lipase inhibition and calorie restriction. Int J Obes. (London) 2005;29:983–990.
Rupnick MA, Panigrahy D, Zhang CY, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci. 2002;99:10703–10735.
Lijnen HR, Frederix L, Van Hoef B. Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity. Obesity (Silver Spring). 2010;18:2241–2246.
Bråkenhielm E, Cao R, Gao B, et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res. 2004;94:1579–1588.
Greenway FL, Liu Z, Yu Y, et al. An assay to measure angiogenesis in human fat tissue. Obes Surg. 2007;17:510–515.
Jung P, Siegrist B, Wade MR, Anthony CT, Woltering EA. Inhibition of human angiogenesis with heparin and hydrocortisone. Angiogenesis. 2001;4:175–186.
Jung SP, Siegrist B, Hornick CA, et al. Effect of human recombinant Endostatin protein on human angiogenesis. Angiogenesis. 2002;5:111–118.
Woltering EA, Lewis JM, Maxwell PJ IV, et al. Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs. Ann Surg. 2003;237:790–798. discussion 798–800.
Hornick CA, Myers A, Sadowska-Krowicka H, Anthony CT, Woltering EA. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni). Angiogenesis. 2003;6:143–149.
Liu Z, Schwimer J, Liu D, Greenway FL, Anthony CT, Woltering EA. Black raspberry extract and fractions contain angiogenesis inhibitors. J Agric Food Chem. 2005;53:3909–3915.
Liu Z, Schwimer J, Liu D, et al. Gallic acid is partially responsible for the antiangiogenic activities of Rubus leaf extract. Phytother Res. 2006;20:806–813.
York DA, Thomas S, Greenway FL, Liu Z, Rood JC. Effect of an herbal extract Number Ten (NT) on body weight in rats. Chin Med. 2007;2:10.
Greenway FL, Liu Z, Martin CK, et al. Safety and efficacy of NT, an herbal supplement, in treating human obesity. Int J Obes (London). 2006;30:1737–1741.
Roberts AT, Martin CK, Liu Z, et al. The safety and efficacy of a dietary herbal supplement and gallic acid for weight loss. J Med Food 2007. 10:184–188.
Glick Z. Modes of action of gallic acid in suppressing food intake of rats. J Nutr. 1981;111:1910–1916.
Booth A, Amen RJ, Scott M, Greenway FL. Oral dose-ranging developmental toxicity study of an herbal supplement (NT) and gallic acid in rats. Adv Ther. 2010;27:250–255.
Lyons JM, Schwimer JE, Anthony CT, et al. The role of VEGF pathways in human physiologic and pathologic angiogenesis. J Surg Res. 2010;159:517–527.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Twiner, E.M., Liu, Z., Gimble, J. et al. Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix. Adv Therapy 28, 857–865 (2011). https://doi.org/10.1007/s12325-011-0061-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-011-0061-x